ArticleEuropean radiology2026
Comparing the detectability of pulmonary nodules on two ultra-high resolution CT scanners: a preliminary phantom study.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- SWI versus T2*GRE for ARIA-H monitoring: a pragmatic perspective on adoption in clinical practice.Neuroradiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo objectively and subjectively compare the detectability of pulmonary nodules on an ultra-high-resolution CT (UHR-CT) scanner equipped with energy-integrating detectors and a photon-counting CT (PCCT) in UHR mode. MATERIALS AND
methodsAn image quality phantom and an anthropomorphic phantom were scanned on a UHR-CT and a PCCT in UHR mode at 7.5/2.5/0.4 mGy. The parameters typically used for UHR chest CT scans were selected. Noise power spectrum and task-based transfer function were computed to assess noise-magnitude, noise texture (f
resultsFor PCCT, noise magnitude increased, and f
conclusionUnder UHR conditions, pulmonary nodule detectability strongly depends on the dose level and reconstruction parameters. High-contrast nodule detection can be performed at all dose levels with both CT systems, but reconstruction strategies must be optimized for low-contrast nodule detection. KEY POINTS: Do the performance of UHR-CT and PCCT scanners improve the detectability of pulmonary nodules? PCCT showed dose-invariant noise texture and higher effective spatial resolution, whereas UHR-CT relied on dose-dependent noise suppression, producing smoother images and reduced spatial frequency. High-contrast nodule detection can be performed at all dose levels with both CT systems, particularly at ultra-low dose levels, but reconstruction strategies must be optimized for low-contrast nodule detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.